摘要:
A monopolar electrosurgical instrument comprising a cylindrical metallic electrode which is connected to one pole of a radio frequency generator on one extreme; said electrode comprising a liquid supply for cooling, a handle 7 that covers part of the electrode, a part 6 covered with an insulative material, and a coagulating and cutting uninsulated tip; said tip comprising a round ending part 2 , a part 3 attached to a cutting metal blade 5 near the end, and a part 4 non-attached to a cutting metal blade. It is useful for precisely cut the tissue that it is previously coagulated, using a single instrument, and avoiding risk of bleeding.
摘要:
An applicator device (1,1) for radiofrequency ablation of biological tissues; the device comprises an electrode whose outer surface is covered with an insulating cover (2, 2") in a proximal portion, and has a conductive distal portion (3,3') whose electrode includes internal refrigeration means (7,7'); an infusion system with a distal end (13, 6) for infusing a fluid in said tissue; wherein said distal end (13, 6) of the infusion system has an electrically insulating outer cover and is located, in the infusion position for said fluid, at a distance between 2 and 5 millimetres from said outer surface of the internally cooled electrode. The invention also concerns a method for ablation by radiofrequency of biological tissues.
摘要:
The present invention is generally related to the prevention of leishmaniasis in animals, particularly infection caused by Leishmania sp., based on the use of Leishmania infantum P36 protein or an immunogenic fragment of the latter, or involving an expression system for the mentioned protein or fragment - optionally in combination with a compound stimulating the production of a Th1-type cellular immune response - and comprising various vaccination protocols in application to Leishmania sp. based on the mentioned vaccine.
摘要:
Polyclonal antibodies,preparation method thereof and use of same. The invention relates to polyclonal antibodies which specifically recognize, and have a strong affinity with, the two most significant amyloid peptides, Aβ40 and Aβ42. The invention also relates to the use thereof in assessing drugs which activate the degradation of amyloid peptides characteristic of Alzheimer's disease as well as drugs which inhibit the formation of same.